HCA Q3 2026 Earnings: Exchange Coverage Losses Cost $400 Million

HCA Healthcare (HCA) reported third-quarter 2026 earnings (July to September) on October 27, 2026, through an 8-K press release and an earnings call. The profit hit from patients losing health insurance exchange coverage did not ease, but one-time state Medicaid supplemental payments and better underlying operations offset it [1][2]. Coming into the quarter, three questions mattered: how much profit HCA would lose as former exchange patients became uninsured, when state supplemental payments would turn into a headwind, and whether underlying demand and cost control could carry growth. The exchange hit was about $400 million in the quarter, and the full-year estimate moved to the top of the prior range or slightly above. The full-year supplemental payment net benefit was raised to $600 million to $800 million, volumes accelerated and unit costs were flat [1][2]. HCA now expects full-year results in the upper half of its guidance, but a large part of that comes from one-time, prior-period benefits, and management's preliminary view is that 2027 earnings will be generally consistent with 2026 [1][2].

HCA is the largest for-profit hospital operator in the United States, with 189 hospitals and about 2,600 ambulatory sites of care as of September 30, 2026 [1]. Florida and Texas together account for about half of its revenue [3]. Patients pay through commercial insurance, Medicare (the federal program for seniors), Medicaid (state programs for low-income people) or out of pocket, so revenue per visit is highly sensitive to payer mix [4].

Exchange coverage losses have not peaked

Exchange patient losses in the third quarter were deeper than HCA's own estimate. The company had expected exchange equivalent admissions (a volume measure that converts outpatient activity into inpatient terms) to fall 15% to 16% year over year; the actual decline was about 19%, although volume rose about 8% from the second quarter [2]. Management said the third quarter of 2025 was the high point for exchange volume, which made the comparison difficult [2]. Patients who lost exchange coverage are still moving almost one-for-one to uninsured status, and uninsured patients rose from 8.5% to about 10.5% of equivalent admissions [2].

The profit impact matched the second quarter, and the full-year estimate moved up again. HCA estimates the payer mix shift reduced third-quarter income before income taxes by about $400 million, the same as the roughly $400 million in the second quarter [1][5]. In July the company had already raised its full-year estimate of the hit to $1.0 billion to $1.2 billion; it now expects the top of that range or slightly above, which the CFO described as $100 million to $200 million of additional headwind [2][6]. The quarter did not show that the hit has peaked. HCA noted an easier fourth-quarter comparison but gave no fourth-quarter assumption [2]. Revenue by payer and the cost of uncompensated care will come with the 10-Q and are unknown for now.

State supplemental payments did not turn into a headwind

State supplemental payments still added about $50 million of incremental net benefit in the third quarter, mainly from a recently approved Virginia program [2]. Under the July full-year guidance of $300 million to $500 million, the second half had implied a $100 million to $300 million headwind [6]. HCA has now raised the full-year range to $600 million to $800 million, with about $650 million recognized through September, and the increase came from the Virginia program and one-time payments across other programs [2].

Receivables booked for state programs in the second quarter were largely collected in the third quarter, but the cost shifts to 2027. Accounts receivable fell from $12.281 billion at the end of June to $11.509 billion at the end of September, and third-quarter operating cash flow was $4.461 billion, slightly above $4.416 billion a year earlier [1]. Because these benefits mostly relate to services in prior periods, HCA expects its supplemental payment net benefit in 2027 to be $550 million to $650 million lower than in 2026, mainly because of Florida [2].

Underlying demand accelerated while unit costs held flat

The core business improved in the quarter, but elective surgery has not stabilized. Same-facility equivalent admissions rose 3.0% and emergency room visits rose 5.1%, while inpatient surgeries fell 1.4% and outpatient surgeries fell 3.7% [1]. Excluding supplemental payments, same-facility cost per equivalent admission was essentially flat year over year and improved 40 basis points from the second quarter [2].

Reported profit growth remained low. Adjusted EBITDA was $3.918 billion, up 1.2%, and the margin fell from 20.2% to 19.7% [1]. The CFO put core growth at about 10%, but did not disclose how that figure is calculated [2].

What the quarter means for HCA's 2026 and 2027 outlook

The third quarter shows that HCA's growth engine is still working, but payer mix continues to squeeze profit conversion. Volumes accelerated and unit costs were flat, yet the shift from exchange coverage to uninsured kept revenue per unit nearly unchanged [1]. Cash generation has recovered as state program receivables were collected [1].

Much of the 2026 cushion comes from one-time benefits, which will shape 2027. HCA expects full-year results in the upper half of its adjusted EBITDA guidance of $15.4 billion to $16.1 billion [1]. Management's preliminary 2027 view calls for 2% to 3% volume growth, a meaningful exchange headwind and earnings generally consistent with 2026 [2]. Whether the exchange hit falls on the easier fourth-quarter comparison, along with open enrollment data and the full guidance due in January, will determine whether this view strengthens or weakens.

Sources

[1] HCA 8-K filed 2026-10-27 · 3Q26 results press release (Exhibit 99.1), 2026-10-27, HCA Healthcare, 8-K Exhibit 99.1 press release, https://www.sec.gov/Archives/edgar/data/0000860730/000119312526432665/hca-ex99_1.htm

[2] HCA 3Q26 earnings call 2026-10-27 · full transcript, 2026-10-27, HCA Healthcare, third-quarter 2026 earnings call transcript

[3] HCA 10-K filed 2026-02-10 · Florida and Texas concentration, 2026-02-10, HCA Healthcare, Form 10-K annual report, https://www.sec.gov/Archives/edgar/data/860730/000119312526044769/hca-20251231.htm

[4] HCA 10-K filed 2026-02-10 · company overview and footprint, 2026-02-10, HCA Healthcare, Form 10-K annual report, https://www.sec.gov/Archives/edgar/data/860730/000119312526044769/hca-20251231.htm

[5] HCA 8-K filed 2026-07-24 · 2Q26 commentary on exchange payer mix and Medicaid supplemental payments, 2026-07-24, HCA Healthcare, 8-K press release, https://www.sec.gov/Archives/edgar/data/860730/000119312526315151/hca-ex99_1.htm

[6] HCA 8-K filed 2026-07-14 · revised 2026 key assumptions: exchanges and Medicaid supplemental payments, 2026-07-14, HCA Healthcare, 8-K press release, https://www.sec.gov/Archives/edgar/data/860730/000119312526302539/hca-ex99_1.htm